Perrigo makes over the counter self care products, infant formula and nutrition products for consumers from its base in Dublin, Ireland. It last closed at $15.78 on Nov 17, down 2.50% on the day.
Only 1 firm rated PRGO in the past 90 days, not enough for a consensus
Average 12-month target
$19.00
▲ 20.4% upside
Based on 1 analyst who set a price target on PRGO in the past 90 days. The average target is $19.00, with a high of $19.00 and a low of $19.00, compared with the last close of $15.78.
Low $19.00Avg $19.00High $19.00
Blue marker: last close $15.78
Highest target$19.00
Average target$19.00
Lowest target$19.00
Latest rating changes
Canaccord GenuityMaintained
Oct 31Buy$19
Date
Firm
Action
Rating
Price target
Oct 31
Canaccord Genuity
Maintained
Buy
$19
Loading…
Seasonality
How PRGO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRGO is in one of them and how their past PRGO trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About PERRIGO Co
Perrigo is a pharmaceutical company based in Dublin, Ireland. It makes self care products, including over the counter medicines, along with infant formula and other nutrition products. Its products are sold to consumers, and it manufactures some of them at facilities in the United States. It also buys raw materials and finished goods from suppliers in other countries.